European Journal of Cancer
Volume 46, Issue 2 , Pages 284-297, January 2010

Redefining the role of interferon in the treatment of malignant diseases

  • Sergio Bracarda

      Affiliations

    • Department of Oncology and U.O.C. of Medical Oncology, Ospedale San Donato, Azienda USL-8, 52100 Arezzo, Italy
    • Corresponding Author InformationCorresponding author: Address: Department of Oncology and U.O.C. of Medical Oncology, Ospedale San Donato, AUSL-8, Via Pietro Nenni, 20, 52100 Arezzo, Italy. Tel.: +39 0575 25 5439; fax: +39 0575 25 5435.
    • ,
  • Alexander M.M. Eggermont

      Affiliations

    • Erasmus University MC – Daniel den Hoed Cancer Center, 3075 EA Rotterdam, The Netherlands
    • ,
  • Jan Samuelsson

      Affiliations

    • Karolinska Institute, Department of Clinical Science and Education, Department of Internal Medicine, Stockholm South Hospital, 118 83 Stockholm, Sweden

Received 28 July 2009; received in revised form 18 September 2009; accepted 9 October 2009. published online 11 November 2009.

Full Text Available

  • Purchase this article for  31.50 USD

    Access is available for 24 hours.

    (Login or Register to purchase)

  • Subscribe to this title
  • Claim access now

    Current subscribers


    • PII: S0959-8049(09)00760-6

    doi:10.1016/j.ejca.2009.10.013

    European Journal of Cancer
    Volume 46, Issue 2 , Pages 284-297, January 2010